| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.34 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |